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1.0 Abstract: Mock circulation loops are used to evaluate the performance of cardiac assist 
devices prior to animal and clinical testing. A compressible, translucent silicone ventricle 
chamber that mimics the exact size, shape and motion of a failing heart is desired to assist in 
flow visualization studies around inflow cannulae during VAD support. The aim of this study 
was therefore to design and construct a naturally shaped flexible left ventricle and evaluate its 
performance in a mock circulation loop.  The ventricle shape was constructed by the use of 
CT images taken from a patient experiencing cardiomyopathic heart failure and used to create 
a 3D image and subsequent mould to produce a silicone ventricle. Different cardiac 
conditions were successfully simulated to validate the ventricle performance, including rest, 
left heart failure and VAD support.  A preliminary flow visualization study was then 
conducted to capture the pattern of fluid flow around the VAD inflow cannula. 
 
  
2.0 Keywords: Ventricular assist device, mock circulation loop, silicone ventricle., flow 
visualization. 
 
3.0 2000 Mathematics subject classification codes: 76M99; 76B75
 
4.0 Introduction 
 
Cardiovascular diseases are attributed with the highest cause of death in the world while the 
need for heart transplantation far exceeds the supply of donor hearts [1] [1].  In the USA 
alone, around 4,000 patients are waiting for a transplant on any given day, while 
approximately 2000 hearts are transplanted annually [2] [2]. This donor shortage creates a 
need for a mechanical device that can assist the heart in its operation until a donor heart can 
be obtained, or until heart function is restored.   
Several designs of Ventricular Assist Devices (VADs) are commercially available or 
under development including Left Ventricular Assist Devices (LVADs) and Bi-Ventricular 
Assist Devices (BiVADs). Before expensive animal or human trials are conducted, mock 
circulation loops can be used to test these assist devices to examine and improve their 
performance.  Mock loops are also required to comply with US Food and Drug 
Administration (FDA) regulations, but are not intended to replace in-vivo trials [3, 4].  
Besides VAD evaluation, mock circulation loops can also be used to examine the 
performance of heart valves, total artificial hearts, and tissue engineered cardiovascular 
therapies. 
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 The first mock circulation systems were primarily used for testing artificial heart 
valves and consisted of pulse duplicators driven by stepping motors to create an artificial 
heart beat [5].  Many of these systems include translucent, flexible ventricles for valve flow 
visualisation, however do not represent the shape and flow characteristics of a dilated 
cardiomyopathic heart [6-11]. Current systems vary from simple, non-pulsatile devices to 
complex devices that imitate the natural haemodynamics of the human circulatory system 
with features such as compliance, resistance, pulsatile flow, feedback mechanisms etc.   
Flexible sacs have been used to create mock ventricles for use in mock circulation 
loops in previous studies [5, 12-16][5-10]. These mock ventricles were hemi-ellipsoid in 
shape rather than having the shape of a true ventricle, and thus flow patterns experienced in 
these ventricles are not indicative of the natural heart.  ADD PULSE DUPLICATOR 
SECTION 
Pantalos et al (2004) used tri-leaflet valves to maintain unidirectional flow while 
pulses of compressed air to the chamber simulated the heartbeat.  This design was noted to 
have higher stiffness while filling and reduced contractility during ejection, which are both 
properties of a natural ventricle in a heart failure patient. 
An anatomically shaped polyurethane ventricle was used by Cassot et al (1985) for 
flow visualization through the ventricle.  Flow patterns were observed for the whole cardiac 
cycle at different angles and vortex zones were identified.  This study was conducted using a 
ventricle based on the shape of a healthy heart; with no flow visualization for VAD 
cannulation [16][10]. 
The mock circulation loop created by Timms et al (2005) is a complex 3-element 
Windkessel, pulsatile system with a systemic and pulmonary circulation including resistance 
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 and compliance components, passively filling ventricles, flow and pressure measures, and the 
ability to easily attach a VAD.  In Timms et al (2005) the ventricles were clear vertical 
chambers that received pulses of compressed air to simulate a heartbeat and were not suitably 
sized to represent the larger ventricular volume of dilated cardiomyopathy patients, or shaped 
to reproduce the flow patterns expected in these failing hearts.  A natural shaped ventricle 
would assist with in-vitro VAD evaluation, particularly with regards to cannula placement 
and ventricular suck-down. By visualizing the pattern of flow within the ventricle during 
VAD support, cannula position may be optimised based on the identification of areas of 
stagnant flow. 
The aim of this study, therefore, was to design and construct a naturally shaped 
flexible left ventricle and evaluate its performance in the mock circulation loop developed by 
Timms et al (2005). 
 
5.0 Methods 
 
5.1 Ventricle chamber design 
 
The natural shaped ventricular chamber was created via a process that involved a number of 
steps. A patient experiencing dilated cardiomyopathic heart failure was identified, and CT 
images of the heart throughout the cardiac cycle were acquired (Figure 1). These images 
consisted of 20 frames per cardiac cycle, with slices of 2mm thickness taken at 11 axial 
positions 10mm apart, from LV apex to atrium.  
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 Visual postprocessing of these images identified the individual frames within each 
axial slice corresponding to the end systolic phase of the cardiac cycle. The end systolic 
period was selected as it represents the ventricle size at minimal preload. These images 
were subsequently imported into MIMICs software (Materialise, Leuven, Belgium), an 
image analysis software tool used to automatically identify tissue of interest from CT/MRI 
scan images. Myocardial tissue from each image was automatically targeted, and selection 
improved with subsequent manual identification. 
The software automatically interpolated the cardiac wall between each slice, to 
create a 3D representation of the ventricular chamber. This was exported as an .STL file to 
a CAD package, PRO/Engineer (Parametric Technologies Corporation, Needham, MA, 
USA) [17][11]. The inner and outer cardiac wall surfaces were selected, separated, and 
offset to create a negative mould of the ventricular wall (Figure 2). These parts were then 
manufactured from ABS plastic using the Stratasys Dimension Fused Deposition 
Modelling machine [18][12].   
The mould was then joined and filled with silicone of shore hardness 15 (Smooth-
On Inc, PA, USA). A translucent silicone with low shore hardness was selected in an 
attempt to allow light to pass and to match the compliant nature of the ventricle wall.  This 
was sufficient for the initial development but as no mechanical testing was carried out to 
verify the required shore hardness of the moulding silicone, the compliance of the mock 
ventricle may not accurately represent that of a cardiomyopathic ventricle.   
 
5.2 Pressure chamber design 
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 The pressure chamber surrounding the silicone ventricle was constructed from clear 
polycarbonate tube so the flow patterns through the ventricle could be monitored.  VAD 
cannula insertion was achieved with a slight clearance fit through a hole in the bottom of 
the pressure chamber.  The cannula then protruded into the silicone ventricle chamber via a 
moulded apical core, with the extended cylindrical silicone wall section clamped to the 
cannula to seal.  
 
 
5.3 Testing of ventricle and chamber 
 
The pressure chamber and silicone ventricle arrangement were attached to the pre-existing 
mock circulation loop for testing (Figure 3). Several different cardiac conditions were 
tested with the silicone ventricle to ensure it could reproduce expected haemodynamic 
results.  
The conditions of (a) healthy heart at rest, (b) left heart failure, and (c) left heart 
failure with rotary (centrifugal) VAD support were undertaken using the systemic side of 
the mock circulation loop only, while a subsequent test at rest was performed including 
both systemic and pulmonary circulations. 
 
5.4 Flow testing  
 
After testing the mock ventricle to ensure it could obtain the appropriate levels of heart 
function, flow visualization tests were attempted to examine the passage of fluid flow 
 through the ventricle and into the cannula.  The aim of this investigation was to examine 
several different cannula positions within the ventricle to determine the position that 
produced the least amount of stagnant flow.  
To accomplish this task, light sensitive, neutrally buoyant particles were circulated 
in the mock loop.  These particles had a diameter of 400 micrometers with a specific 
gravity of 0.95, similar to that of water. A spotlight was used to illuminate the particles, 
with a high speed camera (512x512 resolution @ 20,000 fps) employed to track their 
motion through the ventricle (IDT Inc, FL, USA).  
 
6.0 Results 
 
6.1 Mock ventricle 
 
Results were initially obtained to assess the ability of the mock silicone ventricle to 
reproduce the haemodynamics of a natural ventricle.    
Aortic pressures of 120/80 mmHg at flow rates of 5L/min are experienced at heart 
rates of 60bpm for simulated healthy heart conditions at rest for both systemic circulation 
only (Figure 4) and systemic plus pulmonary circulation (Figure 5). The inclusion of the 
pulmonary circulation was observed to increase left atrial pressure from 6mmHg to 
11mmHg. These haemodynamics were reduced to 80/60 mmHg at 2.3L/min when the LHF 
failure model was induced (Figure 6), but were restored to 110/90 mmHg at 5L/min with 
VAD assistance (Figure 7).  Table 1 presents the critical haemodynamic values for each 
condition.  
 Negative pressures are observed in the silicone left ventricle chamber at end systole 
in each simulated condition except left heart failure.  The magnitude of negative pressure can 
be seen to reduce with the introduction of the pulmonary circulation. 
 
6.2 Flow testing 
 
Images captured by the high speed camera were analyzed in order to observe the light 
sensitive particles.  Figure 8 is an image produced during flow testing phase.  Unfortunately, 
the majority of particles were indistinguishable from the silicone ventricle wall, and therefore 
flow patterns were not effectively observed. 
 
7.0 Discussion 
 
7.1 Ventricle Modelling 
 
The form of mock circulation loops are improved with the use of silicone ventricles, as this 
type of chamber replicates the approximate shape and flexibility of the natural heart. Such a 
flexible and thus collapsible chamber provides the ability to test the response of 
physiological controllers to detect and thus prevent ventricle suckdown [19][13].  
In this study however, the application of this type of ventricular chamber was 
extended to attempt the visualization of flow patterns within a failing heart supported with a 
rotary ventricular assist device.  Apical cannulation of the ventricle disrupts the natural 
pattern of flow within the chamber, and its placement remains critical for successful long 
 term VAD support without thromboembolic complications (18). For example, improper 
positioning of the inflow cannula may cause a partial obstruction of the inflow orifice and 
result in substantial flow restrictions [20-22][14-16]. Therefore, identifying these regions 
by directly visualizing the pattern of flow within the ventricle for a number of cannula 
positions, an optimal cannula location may be identified. However, to improve the 
reproduction of expected flow patterns, the usual elliptical silicone ventricular chamber [5] 
must be replaced with a chamber exhibiting the form of a natural failing heart. A dilated 
cardiomyopathic heart was used in this study, which is characteristically larger (EDV ~ 
280mL) than a normal heart (EDV ~ 150mL). The process of acquiring and postprocessing 
images from a CT scan was effective in reproducing a 3D model of the failing heart, 
however the identification of myocardial tissue from these images was quite time 
consuming. Despite the Mimics™ software approximately identifying the relevant tissue, 
manual selection of false negative sections and trimming of false positive sections was 
required. Other MATLAB™ image processing techniques are being investigated to identify 
the tissue with better automated results.  
When creating the ventricular chamber, the initial volumetric state should represent 
the natural heart’s volume at the end of systole. The simulated myocardial material should 
then have sufficient compliance to accommodate the stroke volume at common atrial 
pressures. A silicone of shore hardness 15 was used in this study. Finally, if compressed 
below this initial starting volume, the chamber would ideally not recoil and thus induce 
negative end systolic pressures. This effect was highlighted during cases of rest and VAD 
support where the heart is decompressed beyond the starting volume to provide the increase 
in stroke volume required to maintain flow rates of 5L/min.  
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 To improve the ventricle performance to accommodate these requirements, it is 
suggested to use a silicone with lower shore hardness, reduce the ventricle wall thickness, 
or use another suitable material.   
Supplying compressed air to the pressure chamber surrounding the silicone ventricle 
to initiate ventricular contractions was effective in producing sufficient cardiac ejection. 
However, this technique fails to reproduce the spiral contraction of the natural heart. This 
limitation, along with the isolation of the left ventricle from the right both act to 
compromise the expected fluid pattern of flow. 
 
7.2 Haemodynamic results 
 
Haemodynamic testing was carried out on the silicone ventricle chamber to ensure it 
could replicate several functional cardiac conditions.  The ventricular and arterial pressure 
waveforms were compared with those experienced naturally. The aortic pressure 
waveforms obtained from the mock circulatory system closely compare with those of 
expected clinical results for each of the cardiac conditions. Pulse pressures are as expected, 
with the VAD condition exhibiting a reduced pulse pressure due to the continuous flow 
nature of support. Delays between ventricular pressure development and transfer to the 
aortic compliance chamber are attributed to the physical distance between these 
components in the circulation loop. 
Atrial pressures are characteristically lower than experienced clinically in each 
result where only the systemic circulation is simulated in the loop. This effect is especially 
evident for conditions of left heart failure, where high left atrial pressures are experienced 
 as symptoms of pulmonary edema, and is attributed to the continued function of the right 
heart to pump blood into the pulmonary circulation. Therefore, the inclusion of the 
pulmonary circulation within a mock loop is essential to reproduce haemodynamics 
characteristic of all cardiac conditions.  
Negative pressures are experienced within the silicone ventricle chamber at end 
systole in all cases where flow rates of 5L/min were simulated. This was attributed to 
overpumping and thus compression of the moulded ventricle beyond its initial end systolic 
size, which resulted in silicone wall recoil and thus somewhat non-passive filling. 
Introducing the pulmonary circulation reduced the magnitude of negative pressure, as the 
higher atrial pressure aided diastolic filling. However, the simulated condition of Heart 
failure completely removed the development of negative pressure. A reduction in flow rate 
for this condition to 2.3L/min (at a fixed heart rate) translates to a reduced stroke volume, 
and thus the end systolic size did not reduce below that initially moulded.   
In this study, the ventricle was modelled from left ventricle images taken from a 
patient experiencing left heart failure.  Therefore, to prevent over compression beyond the 
initial end systolic size and thus generation of negative ventricular pressures, this mould 
should only reproduce low stroke volumes and thus the haemodynamics of a heart failure 
patient. To accurately reproduce resting haemodynamics, a mould taken from images of a 
normal heart would be required.   
 
7.3 Flow testing 
 
 Preliminary visualization of the flow patterns throughout the ventricle was 
ineffective due to the insufficient translucence of the silicone wall. To improve the clarity 
of results, the wall thickness could be reduced from 4mm, and/or investigations could be 
undertaken to replace the type of silicone used, providing the mock ventricle compliance is 
maintained. Furthermore, the high powered spotlight should be replaced by a laser system 
capable of emitting a sheet of light to illuminate specific areas of interest in the ventricle 
chamber, and the ventricle mould should be highly polished to ensure an improved surface 
finish on the silicone. 
 
 
8.0 Conclusion 
 
The silicone ventricle moulded from CT scan images provided a suitable representation of a 
dilated cardiomyopathic heart. The ventricle could reproduce clinically expected 
haemodynamics for a range of cardiac conditions by initiating contraction with pulses of 
compressed air. However, since the ventricle was modelled from a heart failure patient, the 
simulation of heart failure produced the most suitable ventricular pressure results, as the 
stroke volumes were matched. Larger stroke volumes, as required for conditions with 
normal flow rates, compressed the ventricle beyond its initial moulded volume and resulted 
in the development of negative end systolic pressures as the ventricle wall recoiled. 
This device can Preliminary visualization of the flow patterns throughout the 
ventricle was ineffective due to the insufficient translucence of the silicone wall. 
Techniques are being investigated to improve the clarity of results and enable the 
 visualization of flow within the ventricle, and uultimately provide an insight into the 
optimal placement of VAD inflow cannula to reduce areas of stagnation and thus incidence 
of thrombosis.  
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11.0 List of tables 
 
Table 1 – Haemodynamic results for each simulated condition 
Haemodynamic Condition LVESP 
mmHg 
LAP 
mmHg 
MAP 
mmHg 
Flow 
L/min 
(a) Rest 
(b) LHF 
(c) LHF+VAD 
(d) Rest (syst + pulm circ) 
-8.3 
0.2 
-8.5 
-3.1 
5.4 
4.5 
3.8 
10.1 
96.2 
65.8 
96.1 
97.6 
5.2 
2.3 
5.2 
5.0 
LHF = Left Heart Failure, LVESP = Left Ventricular End Systolic Pressure, LAP = Left 
Atrial Pressure, MAP = Mean Arterial Pressure 
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12.0 List of figures 
 
    
Figure 1– CT scan (slice) of a dilated cardiomyopathic heart showing both right ventricular 
(RV) and left ventricular (LV) chambers, and the myocardial wall. RV = Right Ventricle, 
LV = Left Ventricle. 
 
 
  
Figure 2 – Inner and Outer Mould for Silicone Ventricle (need a pic of the actual silicone 
ventricle) 
 
 
 
 
 Figure 3 – Ventricle Chamber/VAD arrangement. The silicone ventricle in the pressure 
chamber can be seen at the top of the figure which is connected through rigid piping to the 
LVAD seen at the bottom of the figure (need a better/cleaner picture) 
 
 
 
 
Figure 4– Pressure and flow tracings for resting conditions. Negative LV pressures were 
apparent during diastole due to the recoiling nature of the silicone ventricle.  LVP = Left 
 Ventricular Pressure, AoP = Aortic Pressure, MAP = Mean Arterial Pressure, LAP = Left 
Atrial Pressure 
 
 
 
 
 
Figure 5– Pressure and flow tracings for full circulation resting conditions. The addition of 
the pulmonary circulation increases LAP and thus raises the negative pressure within the 
 ventricle during diastole. LVP = Left Ventricular Pressure, AoP = Aortic Pressure, MAP = 
Mean Arterial Pressure, LAP = Left Atrial Pressure 
 
 
 
 
 
Figure 6– Pressure and flow tracings for LHF conditions. The LV diastolic pressure 
remains positive, as the flow rate and thus stroke volume is decreased , resulting in reduced 
 movement of the ventricular wall.  LVP = Left Ventricular Pressure, AoP = Aortic 
Pressure, MAP = Mean Arterial Pressure, LAP = Left Atrial Pressure 
 
 
 
 
Figure 7– Pressure and flow tracings for LHF with VAD conditions. Left ventricular systolic 
pressure remains below aortic pressure, indicating the permanent closure of the aortic valve. 
Negative diastolic pressures are again observed, since the VAD decompresses the heart to a 
 volume below its initial end systolic volume. LVP = Left Ventricular Pressure, AoP = Aortic 
Pressure, MAP = Mean Arterial Pressure, LAP = Left Atrial Pressure 
 
 
 
 
Figure 8– Illuminated mock silicone ventricle in systole. Illuminated particles are not 
distinguishable from the ventricular wall. 
 
 
